These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 32996653)

  • 1. Metabolism of short-chain fatty acid propionate induces surface expression of NKG2D ligands on cancer cells.
    Høgh RI; Møller SH; Jepsen SD; Mellergaard M; Lund A; Pejtersen M; Fitzner E; Andresen L; Skov S
    FASEB J; 2020 Nov; 34(11):15531-15546. PubMed ID: 32996653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The narrow-spectrum HDAC inhibitor entinostat enhances NKG2D expression without NK cell toxicity, leading to enhanced recognition of cancer cells.
    Zhu S; Denman CJ; Cobanoglu ZS; Kiany S; Lau CC; Gottschalk SM; Hughes DP; Kleinerman ES; Lee DA
    Pharm Res; 2015 Mar; 32(3):779-92. PubMed ID: 24203492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression.
    Jensen H; Andresen L; Nielsen J; Christensen JP; Skov S
    PLoS One; 2011; 6(8):e23023. PubMed ID: 21857986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propionic acid secreted from propionibacteria induces NKG2D ligand expression on human-activated T lymphocytes and cancer cells.
    Andresen L; Hansen KA; Jensen H; Pedersen SF; Stougaard P; Hansen HR; Jurlander J; Skov S
    J Immunol; 2009 Jul; 183(2):897-906. PubMed ID: 19553547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.
    Møller SH; Mellergaard M; Madsen M; Bermejo AV; Jepsen SD; Hansen MH; Høgh RI; Aldana BI; Desler C; Rasmussen LJ; Sustarsic EG; Gerhart-Hines Z; Daskalaki E; Wheelock CE; Hiron TK; Lin D; O'Callaghan CA; Wandall HH; Andresen L; Skov S
    Front Immunol; 2020; 11():1968. PubMed ID: 32849657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications.
    Jimenez-Perez MI; Jave-Suarez LF; Ortiz-Lazareno PC; Bravo-Cuellar A; Gonzalez-Ramella O; Aguilar-Lemarroy A; Hernandez-Flores G; Pereira-Suarez AL; Daneri-Navarro A; del Toro-Arreola S
    BMC Immunol; 2012 Feb; 13():7. PubMed ID: 22316211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8
    Vadstrup K; Galsgaard ED; Jensen H; Lanier LL; Ryan JC; Chen SY; Nolan GP; Vester-Andersen MK; Pedersen JS; Gerwien J; Jensen T; Bendtsen F
    Exp Mol Pathol; 2017 Aug; 103(1):56-70. PubMed ID: 28684217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulated expression of NKG2D and its ligands give potential therapeutic targets for patients with thymoma.
    Xuan XY; Zhang JF; Hu GM; Li QR; Liu PP; Du Y
    Cancer Gene Ther; 2015 Jul; 22(7):368-74. PubMed ID: 26113176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CBP/p300 acetyltransferases regulate the expression of NKG2D ligands on tumor cells.
    Sauer M; Schuldner M; Hoffmann N; Cetintas A; Reiners KS; Shatnyeva O; Hallek M; Hansen HP; Gasser S; von Strandmann EP
    Oncogene; 2017 Feb; 36(7):933-941. PubMed ID: 27477692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine nucleotide metabolism regulates expression of the human immune ligand MICA.
    McCarthy MT; Moncayo G; Hiron TK; Jakobsen NA; Valli A; Soga T; Adam J; O'Callaghan CA
    J Biol Chem; 2018 Mar; 293(11):3913-3924. PubMed ID: 29279329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
    Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
    J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble ligands for the NKG2D receptor are released during HIV-1 infection and impair NKG2D expression and cytotoxicity of NK cells.
    Matusali G; Tchidjou HK; Pontrelli G; Bernardi S; D'Ettorre G; Vullo V; Buonomini AR; Andreoni M; Santoni A; Cerboni C; Doria M
    FASEB J; 2013 Jun; 27(6):2440-50. PubMed ID: 23395909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia downregulates the expression of cell surface MICA without increasing soluble MICA in osteosarcoma cells in a HIF-1α-dependent manner.
    Yamada N; Yamanegi K; Ohyama H; Hata M; Nakasho K; Futani H; Okamura H; Terada N
    Int J Oncol; 2012 Dec; 41(6):2005-12. PubMed ID: 22992985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A conserved WW domain-like motif regulates invariant chain-dependent cell-surface transport of the NKG2D ligand ULBP2.
    Uhlenbrock F; van Andel E; Andresen L; Skov S
    Mol Immunol; 2015 Aug; 66(2):418-27. PubMed ID: 25983110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium valproate, a histone deacetylase inhibitor, augments the expression of cell-surface NKG2D ligands, MICA/B, without increasing their soluble forms to enhance susceptibility of human osteosarcoma cells to NK cell-mediated cytotoxicity.
    Yamanegi K; Yamane J; Kobayashi K; Kato-Kogoe N; Ohyama H; Nakasho K; Yamada N; Hata M; Nishioka T; Fukunaga S; Futani H; Okamura H; Terada N
    Oncol Rep; 2010 Dec; 24(6):1621-7. PubMed ID: 21042760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma down-regulates NKG2D ligand expression and impairs the NKG2D-mediated cytolysis of MHC class I-deficient melanoma by natural killer cells.
    Schwinn N; Vokhminova D; Sucker A; Textor S; Striegel S; Moll I; Nausch N; Tuettenberg J; Steinle A; Cerwenka A; Schadendorf D; Paschen A
    Int J Cancer; 2009 Apr; 124(7):1594-604. PubMed ID: 19089914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-deoxy D-glucose prevents cell surface expression of NKG2D ligands through inhibition of N-linked glycosylation.
    Andresen L; Skovbakke SL; Persson G; Hagemann-Jensen M; Hansen KA; Jensen H; Skov S
    J Immunol; 2012 Feb; 188(4):1847-55. PubMed ID: 22227571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GAS6/TAM signaling pathway controls MICA expression in multiple myeloma cells.
    Kosta A; Mekhloufi A; Lucantonio L; Zingoni A; Soriani A; Cippitelli M; Gismondi A; Fazio F; Petrucci MT; Santoni A; Stabile H; Fionda C
    Front Immunol; 2022; 13():942640. PubMed ID: 35967396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The HHV-6A Proteins U20 and U21 Target NKG2D Ligands to Escape Immune Recognition.
    Chaouat AE; Seliger B; Mandelboim O; Schmiedel D
    Front Immunol; 2021; 12():714799. PubMed ID: 34721381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A GPI anchor explains the unique biological features of the common NKG2D-ligand allele MICA*008.
    Ashiru O; López-Cobo S; Fernández-Messina L; Pontes-Quero S; Pandolfi R; Reyburn HT; Valés-Gómez M
    Biochem J; 2013 Sep; 454(2):295-302. PubMed ID: 23772752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.